ALX Oncology Holdings Inc.
ALXO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $22 | $49 | $364 |
| Short-Term Investments | $110 | $160 | $217 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $6 | $5 | $3 |
| Total Curr. Assets | $134 | $189 | $271 | $367 |
| Property Plant & Equip (Net) | $10 | $11 | $10 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $4 | $35 | $17 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $8 | $9 | $10 |
| Total NC Assets | $13 | $54 | $36 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $148 | $243 | $306 | $380 |
| Liabilities | – | – | – | – |
| Payables | $4 | $9 | $8 | $4 |
| Short-Term Debt | $2 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $26 | $19 | $11 |
| Total Curr. Liab. | $19 | $36 | $28 | $15 |
| LT Debt | $15 | $16 | $9 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $5 | $2 |
| Total NC Liab. | $16 | $17 | $15 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $8 | $1 | $1 |
| Total Liabilities | $34 | $53 | $43 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$621 | -$486 | -$325 | -$202 |
| AOCI | $0 | $0 | -$1 | $0 |
| Other Equity | $734 | $676 | $590 | $565 |
| Total Equity | $114 | $190 | $263 | $363 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $148 | $243 | $306 | $380 |
| Net Debt | -$1 | -$5 | -$38 | -$363 |